Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymorphone IR oral liquid in pediatric chronic pain
NCT01206907Phase 3Withdrawn
- Sponsor
- Endo International plc
- Start
- Oct 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of oxymorphone in chronic pain, sponsored by Endo International plc. Planned start Oct 2010; status: withdrawn.
02
Drugs
oxymorphone
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT01206907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01206907.